共 50 条
- [23] Microbiologic surrogate end points in infectious diseases: Example of acute clinical trials of otitis media trials PHARMACOTHERAPY, 2005, 25 (12): : 109S - 123S
- [25] A regulatory agency's perspective on the application of biomarkers and surrogate end points in clinical trials BIOMARKERS AND SURROGATE ENDPOINTS: CLINICAL RESEARCH AND APPLICATIONS, 2000, 1205 : XIV - XVIII
- [26] Use of surrogate end points for prostate cancer-related mortality in clinical trials Nature Clinical Practice Oncology, 2009, 6 (2): : 61 - 62
- [29] Surrogate End Points in Trials-SPIRIT and CONSORT Extensions JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (16): : 1340 - 1342
- [30] Small trials focusing on surrogate end points may be uninformative European Journal of Applied Physiology, 2007, 99 : 707 - 708